6,106 Shares in Doximity, Inc. (NASDAQ:DOCS) Bought by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 6,106 shares of the company's stock, valued at approximately $326,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Barclays PLC grew its position in Doximity by 60.5% during the 3rd quarter. Barclays PLC now owns 53,401 shares of the company's stock worth $2,327,000 after purchasing an additional 20,125 shares during the last quarter. Blue Trust Inc. raised its stake in shares of Doximity by 88.1% in the 4th quarter. Blue Trust Inc. now owns 5,398 shares of the company's stock valued at $288,000 after acquiring an additional 2,528 shares during the period. KBC Group NV lifted its stake in shares of Doximity by 2,130.7% in the fourth quarter. KBC Group NV now owns 73,523 shares of the company's stock worth $3,925,000 after acquiring an additional 70,227 shares in the last quarter. Baader Bank Aktiengesellschaft lifted its holdings in Doximity by 85.0% during the 4th quarter. Baader Bank Aktiengesellschaft now owns 11,100 shares of the company's stock worth $593,000 after buying an additional 5,100 shares during the last quarter. Finally, Greenleaf Trust acquired a new position in Doximity during the 4th quarter valued at approximately $228,000. Hedge funds and other institutional investors own 87.19% of the company's stock.

Doximity Stock Performance

Shares of DOCS stock traded up $1.04 on Wednesday, hitting $54.55. 1,928,287 shares of the company's stock traded hands, compared to its average volume of 2,113,288. Doximity, Inc. has a one year low of $25.00 and a one year high of $85.21. The company's fifty day simple moving average is $54.70 and its 200 day simple moving average is $58.08. The stock has a market capitalization of $10.25 billion, a price-to-earnings ratio of 54.55, a P/E/G ratio of 4.10 and a beta of 1.32.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same period last year, the business earned $0.25 earnings per share. Doximity's revenue was up 17.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DOCS. Robert W. Baird dropped their target price on shares of Doximity from $87.00 to $65.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Wells Fargo & Company reissued an "equal weight" rating on shares of Doximity in a research report on Friday, February 7th. JPMorgan Chase & Co. dropped their price objective on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a research note on Tuesday, May 27th. BTIG Research upgraded shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price for the company in a research note on Monday. Finally, William Blair reaffirmed an "outperform" rating on shares of Doximity in a research note on Friday, May 16th. Eleven investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $62.84.

Insider Buying and Selling

In related news, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $52.89, for a total transaction of $105,780.00. Following the completion of the transaction, the director now directly owns 16,618 shares of the company's stock, valued at approximately $878,926.02. This trade represents a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Anna Bryson sold 45,000 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now owns 357,165 shares in the company, valued at approximately $20,440,552.95. This trade represents a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 51,000 shares of company stock worth $2,900,770 in the last quarter. Corporate insiders own 37.40% of the company's stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.